Clinical Trial Update: Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effectiveness and safety of flexible-dose paliperidone extended-release in patients with schizoaffective disorder and psychotic dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorder
• Schizoaffective Disorder

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizoaffective Disorder, Psychotic Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-12-09